Telix Pharmaceuticals Limited: Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid
MELBOURNE, Australia, April 26, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability